#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	20702	16S	1529	1529	100.0	16S.l6.c17.ctg.1	2280	904.8	1	SNP	n	C1184T	0	.	.	1184	1184	C	1539	1539	C	1212	C,T	1094,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	37510	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3521	1062.0	0	.	n	.	0	T695C	SNP	695	695	T	1037	1037	C	1153	C	1056	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	37510	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3521	1062.0	0	.	n	.	0	A1638G	SNP	1638	1638	A	1980	1980	G	1275	G,A	1109,57	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	37510	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3521	1062.0	0	.	n	.	0	T1971C	SNP	1971	1971	T	2313	2313	C	1183	C,T	1064,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	37510	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3521	1062.0	1	SNP	n	A2045G	0	.	.	2045	2045	A	2387	2387	A	1118	A	1031	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	37510	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3521	1062.0	1	SNP	n	C2597T	0	.	.	2597	2597	C	2939	2939	C	1112	C	1016	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	2772	folP	855	855	100.0	folP.l6.c4.ctg.1	1498	183.9	1	SNP	p	R229S	1	.	.	685	687	AGC	996	998	AGC	276;276;278	A,C;G;C	236,14;252;254	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	7516	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3410	219.8	1	SNP	p	S91F	1	.	.	271	273	TTC	610	612	TTC	273;272;274	T;T,C;C	241;221,20;242	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	7516	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3410	219.8	1	SNP	p	D95G	1	.	.	283	285	GGC	622	624	GGC	277;277;278	G;G,A,T;C	244;220,19,1;244	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	7516	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3410	219.8	1	SNP	p	G95N	0	.	.	283	285	GGC	622	624	GGC	277;277;278	G;G,A,T;C	244;220,19,1;244	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	539	2246	mtrR	633	633	99.84	mtrR.l15.c30.ctg.1	1452	154.3	0	.	p	.	0	F184L	NONSYN	550	552	TTC	891	893	TTG	248;248;249	T;T;G,C	230;233;220,11	.	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	539	2246	mtrR	633	633	99.84	mtrR.l15.c30.ctg.1	1452	154.3	1	SNP	p	G45D	0	.	.	133	135	GGC	474	476	GGC	298;295;293	G;G;C	274;269;268	mtrR.WHO_G_01393:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	1038	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c30.ctg.1	1069	96.8	0	.	n	.	0	A197.	DEL	197	197	A	611	611	A	263	A	226	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	7186	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2923	244.8	1	SNP	p	D86N	0	.	.	256	258	GAC	545	547	GAC	277;278;278	G;A;C	254;250;253	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	7186	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2923	244.8	1	SNP	p	S87R	1	.	.	259	261	CGT	548	550	CGT	275;272;273	C,A;G,A;T	246,8;250,1;243	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	7186	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2923	244.8	1	SNP	p	R87I	0	.	.	259	261	CGT	548	550	CGT	275;272;273	C,A;G,A;T	246,8;250,1;243	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	7186	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2923	244.8	1	SNP	p	R87W	0	.	.	259	261	CGT	548	550	CGT	275;272;273	C,A;G,A;T	246,8;250,1;243	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	7186	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2923	244.8	1	SNP	p	S88P	0	.	.	262	264	TCC	551	553	TCC	270;269;271	T;C;C	247;247;251	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	5924	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2667	221.4	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1506	1508	GGC	269;267;266	G;G;C,A	245;244;241,1	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.5.002	penA.5.002	1	1	27	5480	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2363	230.8	1	SNP	p	A311V	0	.	.	931	933	GCA	1229	1231	GCA	307;307;308	G;C;A,C	274;280;278,2	penA.5.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	5480	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2363	230.8	1	SNP	p	I312M	0	.	.	934	936	ATC	1232	1234	ATC	310;312;316	A,G;T;C,G	279,1;283;281,2	penA.5.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	5480	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2363	230.8	1	SNP	p	V316T	0	.	.	946	948	GTG	1244	1246	GTG	321;325;329	G,C,A;T,C;G,C	286,1,1;290,2;293,2	penA.5.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	5480	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2363	230.8	1	SNP	p	V316P	0	.	.	946	948	GTG	1244	1246	GTG	321;325;329	G,C,A;T,C;G,C	286,1,1;290,2;293,2	penA.5.002:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	5480	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2363	230.8	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1748	1750	ACC	282;283;287	A;C;C	246;248;250	penA.5.002:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	5480	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2363	230.8	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1802	1804	GCG	268;265;269	G;C,G;G	236;223,1;228	penA.5.002:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	5480	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2363	230.8	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1802	1804	GCG	268;265;269	G;C,G;G	236;223,1;228	penA.5.002:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	5480	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2363	230.8	1	SNP	p	G543S	1	.	.	1627	1629	AGC	1925	1927	AGC	230;229;228	A,G;G;C,T	198,6;203;197,5	penA.5.002:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	5480	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2363	230.8	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1934	1936	GGC	213;209;211	G;G;C	194;188;191	penA.5.002:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	5480	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2363	230.8	1	SNP	p	P552S	0	.	.	1654	1656	CCG	1952	1954	CCG	186;189;186	C,G,A;C,G;G	138,3,1;143,1;140	penA.5.002:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	7806	ponA	2397	2397	99.92	ponA.l6.c4.ctg.1	3117	249.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	3152	porA	1146	1146	99.91	porA.l6.c4.ctg.1	1750	178.7	0	.	p	.	0	M83fs	FSHIFT	247	247	A	535	535	C	246	C	211	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3892	porB1b	1047	1047	98.95	porB1b.l15.c30.ctg.1	1643	236.1	0	.	p	.	0	N38E	NONSYN	112	114	AAT	563	565	GAA	352;346;343	G;A;A	316;312;309	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3892	porB1b	1047	1047	98.95	porB1b.l15.c30.ctg.1	1643	236.1	0	.	p	.	0	N134D	NONSYN	400	402	AAT	851	853	GAT	332;333;340	G,A;A;T,G	307,1;309;302,11	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3892	porB1b	1047	1047	98.95	porB1b.l15.c30.ctg.1	1643	236.1	0	.	p	.	0	P175S	NONSYN	523	525	CCA	974	976	TCA	312;312;317	T;C,G;A	284;286,1;292	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3892	porB1b	1047	1047	98.95	porB1b.l15.c30.ctg.1	1643	236.1	0	.	p	.	0	Q214R	NONSYN	640	642	CAA	1091	1093	CGA	289;289;286	C;G,A;A	272;264,10;269	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3892	porB1b	1047	1047	98.95	porB1b.l15.c30.ctg.1	1643	236.1	0	.	p	.	0	S217R	NONSYN	649	651	AGT	1100	1102	CGT	285;281;279	C,A;G;T	254,11;264;260	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3892	porB1b	1047	1047	98.95	porB1b.l15.c30.ctg.1	1643	236.1	0	.	p	.	0	A218V	NONSYN	652	654	GCC	1103	1105	GTC	281;278;277	G,A;T;C	248,11;257;260	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3892	porB1b	1047	1047	98.95	porB1b.l15.c30.ctg.1	1643	236.1	0	.	p	.	0	F222S	NONSYN	664	666	TTT	1115	1117	TCT	268;273;276	T;C,T;T	245;243,8;255	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3892	porB1b	1047	1047	98.95	porB1b.l15.c30.ctg.1	1643	236.1	0	.	p	.	0	E328A	NONSYN	982	984	GAA	1433	1435	GCA	325;325;331	G,A;C,A;A	288,1;278,12;294	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3892	porB1b	1047	1047	98.95	porB1b.l15.c30.ctg.1	1643	236.1	1	SNP	p	G120K	1	.	.	358	360	AAG	809	811	AAG	306;307;321	A;A;G	280;277;290	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3892	porB1b	1047	1047	98.95	porB1b.l15.c30.ctg.1	1643	236.1	1	SNP	p	D121N	0	.	.	361	363	GAC	812	814	GAC	324;324;326	G,A;A;C	288,1;286;298	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3892	porB1b	1047	1047	98.95	porB1b.l15.c30.ctg.1	1643	236.1	1	SNP	p	A121D	1	.	.	361	363	GAC	812	814	GAC	324;324;326	G,A;A;C	288,1;286;298	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	14212	rpoB	4179	4179	99.98	rpoB.l6.c30.ctg.1	5049	280.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1570	rpsJ	312	312	100.0	rpsJ.l6.c17.ctg.1	1023	151.8	1	SNP	p	V57M	1	.	.	169	171	ATG	618	620	ATG	335;339;340	A,G;T;G	301,17;320;321	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
